Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Hims & Hers Health in the transaction. Hims & Hers Health, a multi-specialty telehealth platform, announced its acquisition...
Hims & Hers’ Acquisition of 503B Outsourcing Facility MedisourceRx
Flywire’s $256 Million Common Stock Offering
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian acted as counsel to Flywire, and Goodwin Procter acted as counsel to the underwriters. Flywire Corporation (Nasdaq: FLYW) announced its underwritten...
Alimera Sciences’ Acquisition of U.S. Commercial Rights to YUTIQ®
Gunderson Dettmer represented Alimera Sciences on the transaction, while Sidley Austin LLP represented EyePoint Pharmaceuticals, Inc. Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company, has...
Arcus Biosciences’ $200 Million At-the-Market Offering
Gunderson Dettmer advised sales agents Goldman Sachs & Co. LLC and SVB Securities on the deal. Goldman Sachs & Co. LLC and SVB Securities acted as sales agents in...
Backblaze’s IPO
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Backblaze on the deal. White & Case advised Oppenheimer & Co. Backblaze, a provider of cloud storage and...
Uber’s Acquisition of Remaining 47% Interest in Cornershop
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Cornershop on the deal. DLA Piper Chile, Creel Abogados advised Cornershop and Uber Technologies, while Morrison &...